APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurology Software

Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.

Neurology Software provides the sufferers overall health-related information to assist in wellbeing care decisions. The specialist primarily based plan provides forms similar for his or her paper counterparts however provides easy navigation, a typical paragraph and click solution, discernment and also a standardized interface that allows everyone in workout to be more practical and provide far better wellness health-related treatment towards the patient.

Selected research

Market Outlook & Growth Opportunities

Global Neurology Software Market Outlook and Growth Opportunities 2026

1 January 2026199 pages

Choose your research edition.

Industry ResearchNeurology Software Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurology Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Neurology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurology Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurology Software Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.

Neurology Software provides the sufferers overall health-related information to assist in wellbeing care decisions. The specialist primarily based plan provides forms similar for his or her paper counterparts however provides easy navigation, a typical paragraph and click solution, discernment and also a standardized interface that allows everyone in workout to be more practical and provide far better wellness health-related treatment towards the patient.

Viewed from the supply side, there are some manufacturers in the Neurology Software industry such as Epic, Athenahealth, Nextgen, healthfusion, Allscripts, Greenway Health, Practice Fusion, Brainlab, Kareo, Bizmatics, Advanced Data Systems, NueMD, etc. And Epic is the biggest supplier, Xttrium occupied about 14% market share.

Read the full market overview

USA is the biggest market with 42% market share, followed by Europe with 30% market share. We forecast that USA will continue to be the biggest market.

This report provides an overview of the global Neurology Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurology Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurology Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neurology Software market.

Neurology Software Segment by Company

Epic

Athenahealth

Nextgen

healthfusion

Allscripts

Greenway Health

Practice Fusion

Brainlab

Kareo

Bizmatics

Advanced Data Systems

NueMD

Neurology Software Segment by Type

Advanced Neurology EMR Software

Others

Neurology Software Segment by Application

Hospitals

College & Research Institutes

Others

Neurology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neurology Software key companies, revenue, market share, and recent developments.

3. To split the Neurology Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neurology Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurology Software significant trends, drivers, influence factors in global and regions.

6. To analyze Neurology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurology Software industry.

Chapter 3: Detailed analysis of Neurology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neurology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neurology Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurology Software Industry Trends Table 2. Neurology Software Industry Drivers Table 3. Neurology Software Industry Opportunities and Challenges Table 4. Neurology Software Industry Restraints Table 5. Global Neurology Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurology Software Revenue Share by Company (2021-2026) Table 7. Global Neurology Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neurology Software Key Company Manufacturing Base & Headquarters Table 9. Global Neurology Software Company, Product Type & Application Table 10. Global Neurology Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neurology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Advanced Neurology EMR Software Table 15. Significant Companies of Others Table 16. Global Neurology Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Neurology Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Neurology Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Neurology Software Sales Value Share by Type (2021-2026) Table 20. Global Neurology Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of College & Research Institutes Table 23. Significant Companies of Others Table 24. Global Neurology Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Neurology Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Neurology Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Neurology Software Sales Value Share by Application (2021-2026) Table 28. Global Neurology Software Sales Value Share by Application (2027-2032) Table 29. Global Neurology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Neurology Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Neurology Software Sales Value Share by Region (2021-2026) Table 32. Global Neurology Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Neurology Software Sales Value Share by Region (2027-2032) Table 34. Global Neurology Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Neurology Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Neurology Software Sales Value Market Share by Country (2021-2026) Table 37. Global Neurology Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Neurology Software Sales Value Market Share by Country (2027-2032) Table 39. Epic Company Information Table 40. Epic Business Overview Table 41. Epic Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Epic Neurology Software Product Portfolio Table 43. Epic Recent Development Table 44. Athenahealth Company Information Table 45. Athenahealth Business Overview Table 46. Athenahealth Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Athenahealth Neurology Software Product Portfolio Table 48. Athenahealth Recent Development Table 49. Nextgen Company Information Table 50. Nextgen Business Overview Table 51. Nextgen Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Nextgen Neurology Software Product Portfolio Table 53. Nextgen Recent Development Table 54. healthfusion Company Information Table 55. healthfusion Business Overview Table 56. healthfusion Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. healthfusion Neurology Software Product Portfolio Table 58. healthfusion Recent Development Table 59. Allscripts Company Information Table 60. Allscripts Business Overview Table 61. Allscripts Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Allscripts Neurology Software Product Portfolio Table 63. Allscripts Recent Development Table 64. Greenway Health Company Information Table 65. Greenway Health Business Overview Table 66. Greenway Health Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Greenway Health Neurology Software Product Portfolio Table 68. Greenway Health Recent Development Table 69. Practice Fusion Company Information Table 70. Practice Fusion Business Overview Table 71. Practice Fusion Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Practice Fusion Neurology Software Product Portfolio Table 73. Practice Fusion Recent Development Table 74. Brainlab Company Information Table 75. Brainlab Business Overview Table 76. Brainlab Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Brainlab Neurology Software Product Portfolio Table 78. Brainlab Recent Development Table 79. Kareo Company Information Table 80. Kareo Business Overview Table 81. Kareo Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Kareo Neurology Software Product Portfolio Table 83. Kareo Recent Development Table 84. Bizmatics Company Information Table 85. Bizmatics Business Overview Table 86. Bizmatics Neurology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bizmatics Neurology Software Product Portfolio Table 88. Bizmatics Recent Development Table 89. Advanced Data Systems Company Information Table 90. Advanced Data Systems Business Overview Table 91. Advanced Data Systems Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Advanced Data Systems Neurology Software Product Portfolio Table 93. Advanced Data Systems Recent Development Table 94. NueMD Company Information Table 95. NueMD Business Overview Table 96. NueMD Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. NueMD Neurology Software Product Portfolio Table 98. NueMD Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Neurology Software Product Image Figure 2. Global Neurology Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurology Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurology Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Advanced Neurology EMR Software Image Figure 8. Others Image Figure 9. Global Neurology Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Neurology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Neurology Software Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. College & Research Institutes Image Figure 14. Others Image Figure 15. Global Neurology Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Neurology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Neurology Software Sales Value Share by Application (2021-2032) Figure 18. Global Neurology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Neurology Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Neurology Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Neurology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Neurology Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Neurology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Neurology Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Neurology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Neurology Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Neurology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Neurology Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Neurology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Neurology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Neurology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Neurology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Advanced Neurology EMR Software
  • Others
Applications
  • Hospitals
  • College & Research Institutes
  • Others
Companies covered
  • Epic
  • Athenahealth
  • Nextgen
  • healthfusion
  • Allscripts
  • Greenway Health
  • Practice Fusion
  • Brainlab
  • Kareo
  • Bizmatics
  • Advanced Data Systems
  • NueMD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurology Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurology Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neurology Software Market Dynamics
  1. 2.1 Neurology Software Industry Trends
  2. 2.2 Neurology Software Industry Drivers
  3. 2.3 Neurology Software Industry Opportunities and Challenges
  4. 2.4 Neurology Software Industry Restraints
3 Neurology Software Market by Company
  1. 3.1 Global Neurology Software Company Revenue Ranking in 2025
  2. 3.2 Global Neurology Software Revenue by Company (2021-2026)
  3. 3.3 Global Neurology Software Company Ranking (2024-2026)
  4. 3.4 Global Neurology Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Neurology Software Company Product Type and Application
  6. 3.6 Global Neurology Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neurology Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neurology Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neurology Software Market by Type
  1. 4.1 Neurology Software Type Introduction
  2. 4.1.1 Advanced Neurology EMR Software
  3. 4.1.2 Others
  4. 4.2 Global Neurology Software Sales Value by Type
  5. 4.2.1 Global Neurology Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neurology Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Neurology Software Sales Value Share by Type (2021-2032)
5 Neurology Software Market by Application
  1. 5.1 Neurology Software Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 College & Research Institutes
  4. 5.1.3 Others
  5. 5.2 Global Neurology Software Sales Value by Application
  6. 5.2.1 Global Neurology Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurology Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Neurology Software Sales Value Share by Application (2021-2032)
6 Neurology Software Regional Value Analysis
  1. 6.1 Global Neurology Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurology Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neurology Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neurology Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurology Software Sales Value (2021-2032)
  7. 6.3.2 North America Neurology Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neurology Software Sales Value (2021-2032)
  10. 6.4.2 Europe Neurology Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neurology Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neurology Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neurology Software Sales Value (2021-2032)
  16. 6.6.2 South America Neurology Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neurology Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neurology Software Sales Value Share by Country, 2025 VS 2032
7 Neurology Software Country-level Value Analysis
  1. 7.1 Global Neurology Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurology Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neurology Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neurology Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neurology Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neurology Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neurology Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neurology Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neurology Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neurology Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neurology Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neurology Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neurology Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neurology Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neurology Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neurology Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neurology Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neurology Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neurology Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neurology Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neurology Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neurology Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neurology Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neurology Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neurology Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neurology Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neurology Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neurology Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neurology Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neurology Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neurology Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neurology Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neurology Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neurology Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neurology Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neurology Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neurology Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neurology Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neurology Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neurology Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neurology Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neurology Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neurology Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neurology Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neurology Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neurology Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neurology Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neurology Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neurology Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neurology Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neurology Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neurology Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neurology Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neurology Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neurology Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neurology Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neurology Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neurology Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neurology Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neurology Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neurology Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neurology Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neurology Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neurology Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neurology Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neurology Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neurology Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neurology Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neurology Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neurology Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neurology Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neurology Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neurology Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neurology Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neurology Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neurology Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neurology Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neurology Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neurology Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neurology Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neurology Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neurology Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neurology Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neurology Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neurology Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neurology Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neurology Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neurology Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Epic
  2. 8.1.1 Epic Company Information
  3. 8.1.2 Epic Business Overview
  4. 8.1.3 Epic Neurology Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Epic Neurology Software Product Portfolio
  6. 8.1.5 Epic Recent Developments
  7. 8.2 Athenahealth
  8. 8.2.1 Athenahealth Company Information
  9. 8.2.2 Athenahealth Business Overview
  10. 8.2.3 Athenahealth Neurology Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Athenahealth Neurology Software Product Portfolio
  12. 8.2.5 Athenahealth Recent Developments
  13. 8.3 Nextgen
  14. 8.3.1 Nextgen Company Information
  15. 8.3.2 Nextgen Business Overview
  16. 8.3.3 Nextgen Neurology Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nextgen Neurology Software Product Portfolio
  18. 8.3.5 Nextgen Recent Developments
  19. 8.4 healthfusion
  20. 8.4.1 healthfusion Company Information
  21. 8.4.2 healthfusion Business Overview
  22. 8.4.3 healthfusion Neurology Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 healthfusion Neurology Software Product Portfolio
  24. 8.4.5 healthfusion Recent Developments
  25. 8.5 Allscripts
  26. 8.5.1 Allscripts Company Information
  27. 8.5.2 Allscripts Business Overview
  28. 8.5.3 Allscripts Neurology Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Allscripts Neurology Software Product Portfolio
  30. 8.5.5 Allscripts Recent Developments
  31. 8.6 Greenway Health
  32. 8.6.1 Greenway Health Company Information
  33. 8.6.2 Greenway Health Business Overview
  34. 8.6.3 Greenway Health Neurology Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Greenway Health Neurology Software Product Portfolio
  36. 8.6.5 Greenway Health Recent Developments
  37. 8.7 Practice Fusion
  38. 8.7.1 Practice Fusion Company Information
  39. 8.7.2 Practice Fusion Business Overview
  40. 8.7.3 Practice Fusion Neurology Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Practice Fusion Neurology Software Product Portfolio
  42. 8.7.5 Practice Fusion Recent Developments
  43. 8.8 Brainlab
  44. 8.8.1 Brainlab Company Information
  45. 8.8.2 Brainlab Business Overview
  46. 8.8.3 Brainlab Neurology Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Brainlab Neurology Software Product Portfolio
  48. 8.8.5 Brainlab Recent Developments
  49. 8.9 Kareo
  50. 8.9.1 Kareo Company Information
  51. 8.9.2 Kareo Business Overview
  52. 8.9.3 Kareo Neurology Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kareo Neurology Software Product Portfolio
  54. 8.9.5 Kareo Recent Developments
  55. 8.10 Bizmatics
  56. 8.10.1 Bizmatics Company Information
  57. 8.10.2 Bizmatics Business Overview
  58. 8.10.3 Bizmatics Neurology Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bizmatics Neurology Software Product Portfolio
  60. 8.10.5 Bizmatics Recent Developments
  61. 8.11 Advanced Data Systems
  62. 8.11.1 Advanced Data Systems Company Information
  63. 8.11.2 Advanced Data Systems Business Overview
  64. 8.11.3 Advanced Data Systems Neurology Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Advanced Data Systems Neurology Software Product Portfolio
  66. 8.11.5 Advanced Data Systems Recent Developments
  67. 8.12 NueMD
  68. 8.12.1 NueMD Company Information
  69. 8.12.2 NueMD Business Overview
  70. 8.12.3 NueMD Neurology Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NueMD Neurology Software Product Portfolio
  72. 8.12.5 NueMD Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst